Red Raspberry Leaf — Research Profile

Most midwives and the clinical studies recommend starting at 32 weeks of pregnancy. Some practitioners suggest gradually introducing it from 28 weeks with one cup daily, building to 2-3 cups by 32 weeks. It is generally advised to avoid red raspberry leaf in the first trimester due to theoretical concerns about uterine stimulation during early pregnancy. Always discuss with your midwife or obstetrician before starting.

No — red raspberry leaf does not appear to induce labor or cause premature contractions at normal doses. The Simpson et al. (2001) RCT found no increase in premature labor onset. The herb appears to tone the uterine muscle (improving coordination and efficiency of contractions) rather than stimulate contractions directly. Think of it as preparing the uterus, not triggering it. However, if you experience regular contractions after starting it, discontinue and consult your provider.

Yes. Red raspberry leaf tea has been traditionally used outside of pregnancy for menstrual health, mild cramps, and as a general uterine tonic. It is caffeine-free and provides minerals including iron and calcium. Non-pregnant women can drink 1-3 cups daily. It is also commonly recommended during the postpartum period to support uterine recovery.

No head-to-head trial has compared forms of red raspberry leaf. The only randomized evidence used 1.2 g tablets taken twice daily, while observational and traditional use is mostly as a tea, with studies spanning roughly 1 to 8 cups daily. Since no form has been shown superior, a "best" form cannot be claimed from the evidence.

The claimed benefits center on labour, and the evidence is weak. A double-blind RCT of 192 first-time mothers taking 2.4 g/day from 32 weeks found a shorter second stage of labour (mean difference about 9.6 minutes) and fewer forceps deliveries (19.3% vs 30.4%), but no significant effect on first-stage length or overall birth outcomes. A systematic review concluded human studies show neither clear harm nor benefit and that robust evidence is still lacking.

No standardized dose is established. The one RCT used 2.4 g/day (two 1.2 g tablets) started at 32 weeks of pregnancy, while tea-based use in the literature ranged widely, roughly 1 to 8 cups daily. The systematic review noted that even the RCT's dose may have been sub-therapeutic, so an optimal daily amount has not been defined.

Time of day has not been studied for red raspberry leaf. In the RCT, the relevant timing was gestational: dosing began at 32 weeks and continued until labour started, not at any particular hour. There is no evidence that morning versus evening dosing makes any difference.

In the double-blind RCT, no adverse effects were reported for mother or baby at 2.4 g/day, and a systematic review of human studies found no documented harm from oral use. The only specific adverse event recorded is a single case of hypoglycaemia in a woman with insulin-requiring gestational diabetes after drinking raspberry leaf tea. Beyond that isolated report, no consistent or common side effects have been established for oral red raspberry leaf.

Formal drug-interaction studies are lacking for red raspberry leaf. The one documented signal is with blood-glucose-lowering therapy: a woman with insulin-requiring gestational diabetes developed hypoglycaemia after drinking raspberry leaf tea, so caution with insulin or other glucose-lowering drugs is reasonable. No other medication interactions have been established in trials.

Red raspberry leaf has been studied almost exclusively in low-risk women in late pregnancy as a possible way to shorten labour, and even there the evidence is weak. It has not been shown to benefit anyone outside that context. Given the reported hypoglycaemia case, women with gestational diabetes or anyone on glucose-lowering medication should be especially cautious, and use in pregnancy is best discussed with a maternity care provider.

Red raspberry leaf is not taken for a day-to-day felt effect, so no meaningful onset window has been established. The only measured outcome in a controlled trial was on labour: women took two 1.2 g tablets daily from 32 weeks of pregnancy until labour began, and the effect (a slightly shorter second stage and fewer forceps deliveries) was seen at birth, not as something noticeable earlier. Outside of late pregnancy, no trial has defined a timeframe for any result.

Long-term safety data are essentially absent. The best-studied regimen is short-term late-pregnancy use, roughly from 32 weeks to labour (about 8 weeks), in a double-blind RCT that reported no adverse effects for mother or baby at 2.4 g/day. A systematic review of human studies found neither clear harm nor benefit and rated the overall evidence weak, and no trial has evaluated continuous daily use beyond a pregnancy timeframe.

No upper limit has been established for red raspberry leaf. A systematic review found oral consumption produced no toxicity in humans, and toxicity in animals appeared only with high-dose intravenous or intraperitoneal injection rather than oral intake. Human trials used up to about 2.4 g/day of tablets; the main documented harm at ordinary intake was a single case of hypoglycaemia in a woman with insulin-requiring gestational diabetes after drinking the tea.

There are no supplement-combination trials for red raspberry leaf, so any "stack" claim is unsupported. The one documented interaction concern is with blood-sugar-lowering agents: a woman with insulin-treated gestational diabetes developed hypoglycaemia after drinking the tea, so caution is warranted alongside anything that lowers blood glucose. Otherwise there is no evidence on how it behaves when taken with other supplements.

Red raspberry leaf has no established active-constituent marker, so it is not standardized the way some botanicals are. Trials used either a defined tablet dose (1.2 g tablets) or loose-leaf tea of Rubus idaeus leaf. Look for products that clearly name Rubus idaeus leaf with a stated weight per serving; because these products are not FDA-regulated, potency and content vary between brands.